Shelton Capital Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $391K | Sell |
1,004
-39
| -4% | -$16.5K | 0.01% | 445 |
|
|
2026
Q1 | $494K | Sell |
1,043
-105
| -9% | -$52.9K | 0.01% | 358 |
|
|
2025
Q4 | $536K | Hold |
1,148
| – | – | 0.01% | 332 |
|
|
2025
Q3 | $489K | Sell |
1,148
-42
| -4% | -$16.3K | 0.01% | 357 |
|
|
2025
Q2 | $456K | Sell |
1,190
-37
| -3% | -$13.3K | 0.01% | 359 |
|
|
2025
Q1 | $424K | Sell |
1,227
-39
| -3% | -$12.5K | 0.01% | 363 |
|
|
2024
Q4 | $380K | Hold |
1,266
| – | – | 0.01% | 413 |
|
|
2024
Q3 | $515K | Sell |
1,266
-4,903
| -79% | -$1.8M | 0.01% | 341 |
|
|
2024
Q2 | $1.98M | Sell |
6,169
-6,700
| -52% | -$2.18M | 0.05% | 241 |
|
|
2024
Q1 | $4.29M | Sell |
12,869
-10,000
| -44% | -$3.06M | 0.12% | 179 |
|
|
2023
Q4 | $6.19M | Buy |
22,869
+53
| +0.2% | +$13.1K | 0.2% | 124 |
|
|
2023
Q3 | $5.61M | Hold |
22,816
| – | – | 0.21% | 124 |
|
|
2023
Q2 | $6.92M | Buy |
22,816
+8,493
| +59% | +$2.36M | 0.25% | 95 |
|
|
2023
Q1 | $3.78M | Buy |
14,323
+1,323
| +10% | +$336K | 0.16% | 142 |
|
|
2022
Q4 | $3.12M | Sell |
13,000
-1,436
| -10% | -$322K | 0.33% | 103 |
|
|
2022
Q3 | $2.65M | Buy |
14,436
+4,872
| +51% | +$971K | 0.13% | 172 |
|
|
2022
Q2 | $1.61M | Hold |
9,564
| – | – | 0.07% | 226 |
|
|
2022
Q1 | $2.4M | Buy |
9,564
+8,000
| +512% | +$2.01M | 0.09% | 212 |
|
|
2021
Q4 | $402K | Sell |
1,564
-159
| -9% | -$38.9K | 0.01% | 440 |
|
|
2021
Q3 | $418K | Hold |
1,723
| – | – | 0.02% | 411 |
|
|
2021
Q2 | $356K | Hold |
1,723
| – | – | 0.01% | 495 |
|
|
2021
Q1 | $325K | Sell |
1,723
-71
| -4% | -$12.5K | 0.01% | 526 |
|
|
2020
Q4 | $295K | Sell |
1,794
-13,500
| -88% | -$1.97M | 0.01% | 499 |
|
|
2020
Q3 | $1.91M | Sell |
15,294
-1,184
| -7% | -$147K | 0.08% | 267 |
|
|
2020
Q2 | $1.6M | Sell |
16,478
-600
| -4% | -$62.4K | 0.09% | 203 |
|
|
2020
Q1 | $1.53M | Sell |
17,078
-1,300
| -7% | -$168K | 0.11% | 175 |
|
|
2019
Q4 | $2.72M | Sell |
18,378
-38,931
| -68% | -$5.23M | 0.15% | 134 |
|
|
2019
Q3 | $6.9M | Buy |
57,309
+4,000
| +8% | +$517K | 0.41% | 55 |
|
|
2019
Q2 | $7.21M | Buy |
53,309
+48,575
| +1,026% | +$6.14M | 0.42% | 56 |
|
|
2019
Q1 | $36.3K | Sell |
4,734
-25,975
| -85% | -$3.49M | 0.14% | 147 |
|
|
2018
Q4 | $3.82M | Buy |
30,709
+5,000
| +19% | +$671K | 0.26% | 86 |
|
|
2018
Q3 | $3.58M | Buy |
25,709
+23,500
| +1,064% | +$2.93M | 0.2% | 104 |
|
|
2018
Q2 | $227K | Hold |
2,209
| – | – | 0.01% | 725 |
|
|
2018
Q1 | $214K | Buy |
+2,209
| New | +$214K | 0.01% | 743 |
|
|
2016
Q4 | – | Sell |
-3,409
| Closed | -$258K | – | 880 |
|
|
2016
Q3 | $258K | Sell |
3,409
-100
| -3% | -$7.66K | 0.02% | 633 |
|
|
2016
Q2 | $270K | Buy |
+3,509
| New | +$277K | 0.02% | 592 |
|
|
2015
Q3 | – | Sell |
-2,309
| Closed | -$209K | – | 753 |
|
|
2015
Q2 | $209K | Buy |
+2,309
| New | +$185K | 0.02% | 731 |
|
Other funds holding HCA
Shelton Capital Management's HCA Position: Q2 2026 in Review
Shelton Capital Management reduced its HCA Healthcare (HCA) stake by 3.7% in Q2 2026, selling an estimated $16.5K and leaving 1,004 shares worth $391K. The position accounts for 0.01% of the portfolio, ranked #445.
Shelton Capital Management first reported a position in HCA in Q2 2015 and has held it in 37 quarters since. The position peaked at $7.21M in Q2 2019. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Shelton Capital Management held 1,004 shares of HCA Healthcare worth $391K as of Q2 2026.
- Shelton Capital Management sold 39 HCA Healthcare shares in Q2 2026, an estimated $16.5K.
- HCA Healthcare made up 0.01% of Shelton Capital Management's portfolio in Q2 2026, its #445 holding.
- Shelton Capital Management first reported a position in HCA Healthcare in Q2 2015 and has held it in 37 quarters since.
- Shelton Capital Management's HCA Healthcare position peaked at $7.21M in Q2 2019.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Shelton Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.